• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    US Healthcare Cold Chain Logistics Market

    ID: MRFR/HC/43353-HCR
    200 Pages
    Rahul Gotadki
    September 2025

    US Healthcare Cold Chain Logistics Market Size, Growth Research Report By Mode of Delivery (Last-Mile Delivery, Hubs-to-Distributor), By Product (Vaccines, Biopharmaceuticals, Clinical Trial Materials), By Services (Transportation, Storage, Packaging, Labeling, Others), By End User (Hospitals Clinics, Pharmaceutical, Biopharmaceutical, Biotechnology Companies, Others) and By Temperature Range (Ambient, Refrigerated, Frozen, Cryogenic) - Competitor Industry Analysis and Trends Forecast Till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Table of Contents

    US Healthcare Cold Chain Logistics Market Summary

    Key Market Trends & Highlights

    US Healthcare Cold Chain Logistics Market Trends

    The U.S. Healthcare Cold Chain Logistics Market is experiencing significant trends driven by a growing demand for temperature-sensitive pharmaceuticals and biological products. The rising incidence of chronic diseases and the increased emphasis on vaccinations have accelerated the need for efficient chain solutions. These key market drivers are pivotal as healthcare providers and manufacturers seek to ensure the safety and efficacy of their products during storage and transport.

    Furthermore, advancements in technology, such as the use of blockchain for tracking shipments and real-time monitoring systems, are revolutionizing the logistics process, enhancing transparency and traceability.Opportunities in this market area present themselves through the increasing innovation in cold chain technologies. For instance, there is a rising interest in eco-friendly packaging and sustainable practices that can meet regulatory requirements while also appealing to consumers. The recent push towards personalized medicine is also creating a demand for more specialized transportation solutions tailored to the unique storage and shipping requirements of individual therapies.

    Trends in recent times also indicate a growing reliance on third-party logistics (3PL) providers, which deliver enhanced efficiency and reduce costs for healthcare companies.The COVID-19 pandemic has notably accelerated the adoption of cold chain logistics as healthcare systems realized the importance of efficient distribution channels for critical vaccines. Compliance with strict regulatory standards, such as those set by the FDA, continues to shape operational practices within the U.S. market, ensuring that cold chain logistics meet the highest quality and safety benchmarks.

    As a result, stakeholders are compelled to adapt to these evolving trends to remain competitive and meet market demands effectively.

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    US Healthcare Cold Chain Logistics Market Drivers

    Market Segment Insights

    Healthcare Cold Chain Logistics Market Mode of Delivery Insights

    The Mode of Delivery segment within the U.S. Healthcare Cold Chain Logistics Market plays a crucial role in ensuring the safe transportation of temperature-sensitive medical products, including pharmaceuticals and biologics. This segment is critical as it directly impacts the efficacy of drugs, which require strict temperature control throughout the distribution process.

    Among the various types of delivery services, Last-Mile Delivery stands out as a vital component, representing the final step of the supply chain where products reach healthcare facilities and end consumers.This phase is particularly significant as it accounts for a substantial portion of logistical costs and involves unique challenges such as temperature monitoring and timely delivery to maintain product integrity. Hubs-to-Distributor logistics serves another essential function, facilitating bulk shipments from manufacturers or distribution centers to various healthcare providers.

    In this context, the efficiency of hub operations and the effectiveness of temperature-controlled transport fleets are pivotal in meeting regulatory compliance and maintaining the cold supply chain's reliability.As the U.S. healthcare landscape evolves, driven by factors such as increased demand for biopharmaceuticals and rising patient expectations for timely access to medications, the interplay between Last-Mile Delivery and Hubs-to-Distributor operations becomes more pronounced. Together, these delivery methodologies shape the logistics framework, adapting to the needs of healthcare providers and aligning with cutting-edge technologies aimed at optimizing the U.S. Healthcare Cold Chain Logistics Market efficiency.

    These operations are likely to embrace innovations like IoT solutions, advanced tracking systems, and improved packaging techniques to further enhance service reliability and safeguard product integrity throughout the supply chain.The combination of these elements will remain vital for sustaining the growth and effectiveness of cold chain logistics in the healthcare sector. As a result, the Mode of Delivery segment will continue to be a focal point for stakeholders aiming to improve operational efficiency and ensure compliance with stringent regulatory requirements within the U.S. market.

    US Healthcare Cold Chain Logistics Market Segment

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Healthcare Cold Chain Logistics Market Product Insights

    The U.S. Healthcare Cold Chain Logistics Market is characterized by its diverse array of products essential for maintaining the integrity of temperature-sensitive healthcare goods. Among these, vaccines play a crucial role, particularly as vaccination efforts surge across the country due to public health initiatives, driving demand for robust cold chain capabilities. Biopharmaceuticals, which require stringent temperature control, represent a significant portion of the market as advancements in biologics continue to expand the therapeutic landscape.Clinical trial materials also constitute an important segment, where proper logistics are vital to ensure the efficacy and reliability of trial outcomes.

    The overarching market growth is propelled by rising healthcare demands, increased awareness of biopharmaceutical efficacy, and the escalating number of clinical trials in the U.S. However, challenges such as regulatory compliance and maintaining temperature integrity during distribution persist. Opportunities exist in technological advancements like IoT-enabled tracking and automation, which can enhance operational efficiency, thereby deepening the U.S. Healthcare Cold Chain Logistics Market statistics.This area of focus reflects a dynamic landscape that is instrumental to patient safety and treatment efficacy across the nation.

    Healthcare Cold Chain Logistics Market Services Insights

    The Services segment of the U.S. Healthcare Cold Chain Logistics Market plays a vital role in ensuring temperature-sensitive products are stored, transported, and handled correctly throughout the supply chain. This segment includes critical areas such as Transportation, Storage, Packaging, Labeling, and others, which work collectively to enhance efficiency and compliance with healthcare regulations. Transportation services are essential for timely of pharmaceuticals and biologics, crucial for patient care.

    Storage services provide controlled environments that safeguard product integrity and efficacy, which is especially important given the stringent regulations imposed by regulatory bodies like the FDA.Additionally, Packaging solutions are evolving with advanced technologies that help maintain temperature control, minimize spoilage, and ensure traceability. Labeling, often overlooked, is significant for compliance and provides essential information to end-users, thereby enhancing safety and traceability in the supply chain.

    As the demand for biopharmaceuticals increases, the Services segment is expected to dominate the Healthcare Cold Chain Logistics Market due to its critical function in maintaining product quality and compliance across the healthcare industry.Market trends show that innovations in logistics technology, along with increased healthcare spending in the U.S., continue to drive the growth of these services.

    Healthcare Cold Chain Logistics Market End User Insights

    The U.S. Healthcare Cold Chain Logistics Market, particularly in the End User segment, showcases a diverse range of applications crucial for maintaining the integrity of temperature-sensitive products. Hospitals and clinics are pivotal players in this market, responsible for the safe storage and transportation of vaccines and critical medications, ensuring patient safety and effective treatment.

    The pharmaceutical and biopharmaceutical companies significantly rely on cold chain logistics to manage the distribution of various pharmaceutical products, especially biologics and monoclonal antibodies, which require stringent temperature control throughout their supply chain. Moreover, biotechnology companies play an increasingly important role in innovation and the development of therapies, relying heavily on reliable cold chain solutions to preserve product efficacy during transit. Other industries, too, contribute to the market, as the demand for temperature-controlled management in logistics extends beyond traditional healthcare, emphasizing the importance of maintaining the cold supply chain.

    Overall, the market dynamics reflect a growing emphasis on regulatory compliance and the adoption of advanced technologies, which drive the need for robust cold chain logistics solutions within the U.S. healthcare landscape.

    Healthcare Cold Chain Logistics Market Temperature Range Insights

    The Temperature Range segment of the U.S. Healthcare Cold Chain Logistics Market encompasses various critical classifications, each playing a vital role in ensuring the efficacy of healthcare products. Ambient storage, which typically involves standard room temperature, supports the distribution of non-perishable medical supplies. Refrigerated logistics maintains the integrity of temperature-sensitive medications and biologics vital for patient safety, while Frozen storage is essential for the preservation of specific vaccines and blood products that require sub-zero temperatures.

    Cryogenic storage represents a specialized domain crucial for the transportation of stem cells and certain laboratory specimens, necessitating precise temperature control. The importance of each area is underscored by their significant contribution to the overall reliability of the healthcare supply chain. With the growing need for effective distribution channels, market growth within this segment is propelled by technological advancements and increasing demand for temperature-specific logistics solutions.

    These aspects reinforce their dominance in the U.S. market, ashealthcare providers increasingly depend on optimal temperature management to ensure product safety and compliance with regulatory standards.

    Regional Insights

    Key Players and Competitive Insights

    The U.S. Healthcare Cold Chain Logistics Market is a highly specialized sector that is integral to ensuring the integrity and efficacy of temperature-sensitive medical products, including pharmaceuticals, vaccines, and biologics. As the demand for advanced healthcare solutions continues to rise, so does the complexity and competitiveness of logistics services tailored to this niche.

    Healthcare providers, pharmaceutical companies, and biotechnology firms are increasingly reliant on robust cold chain logistics to maintain compliance with regulatory standards, mitigate risks associated with temperature fluctuations, and deliver products efficiently. The competitive landscape is characterized by innovation and investment, leading to the emergence of new technologies and practices that enhance visibility and traceability throughout the supply chain.

    Panalpina has positioned itself as a significant player in the U.S. Healthcare Cold Chain Logistics Market by leveraging advanced technology and processes to ensure the safe transport of perishable healthcare products. With a strong focus on operational excellence, Panalpina emphasizes temperature monitoring and adherence to compliance requirements, thereby building trust among clients in the pharmaceutical sector.

    The company's established network enables it to offer comprehensive solutions, including transportation management and customs clearance services tailored for healthcare products. With its commitment to quality and reliability, Panalpina has fostered deep partnerships within the industry, facilitating a competitive edge that allows it to respond effectively to the dynamic needs of the healthcare market. Kuehne + Nagel has a robust presence in the U.S. Healthcare Cold Chain Logistics Market, characterized by its diverse portfolio of services and extensive global network.

    The company specializes in providing a range of logistics solutions specifically designed for the transport of sensitive healthcare products, including temperature-controlled storage, freight forwarding, and dedicated compliance services. Kuehne + Nagel has invested significantly in technology and innovation to enhance cold chain visibility and efficiency, offering clients real-time tracking and monitoring capabilities. Their strategy includes strategic mergers and acquisitions aimed at expanding service capabilities and geographical reach within the healthcare sector.

    With a strong brand reputation for quality and reliability, Kuehne + Nagel continues to solidify its position as a leader in logistics solutions for the U.S. healthcare industry while adapting to the evolving landscape and demands of this critical market.

    Industry Developments

    In recent months, the U.S. Healthcare Cold Chain Logistics Market has observed significant developments. Companies such as UPS and FedEx have enhanced their cold storage solutions and transportation capacities in response to the increasing demand for temperature-sensitive pharmaceuticals and vaccines. As of September 2023, Thermo Fisher Scientific announced an expansion of its cold chain capabilities, which aligns with the rising trend of biological and biosimilar product shipments.

    Additionally, Lineage Logistics has reported investments to optimize storage solutions that meet stringent regulatory requirements for biopharmaceuticals.Mergers and acquisitions have also been notable in this sector; for instance, in August 2023, AmerisourceBergen completed its acquisition of a major cold chain-focused logistics provider, reinforcing its position in the healthcare supply chain. Meanwhile, Cardinal Health has strategic partnerships with companies like DB Schenker to enhance logistical efficiencies.

    The market has witnessed a growth trajectory, with new investments driving innovation in tracking and monitoring technologies, increasing overall operational transparency. These advancements reflect a robust response to the ongoing challenges of supply chain disruptions experienced since the COVID-19 pandemic. The U.S. government continues to emphasize robust logistics frameworks as critical to the resilience of healthcare supply chains.

    U.S.

    Market Segmentation

    Outlook

    • Ambient
    • Refrigerated
    • Frozen
    • Cryogenic

    Healthcare Cold Chain Logistics Market Product Outlook

    • Transportation
    • Storage
    • Packaging
    • Labeling
    • Others

    Healthcare Cold Chain Logistics Market End User Outlook

    • Ambient
    • Refrigerated
    • Frozen
    • Cryogenic

    Healthcare Cold Chain Logistics Market Services Outlook

    • HospitalsClinics
    • Pharmaceutical
    • Biopharmaceutical
    • Biotechnology Companies
    • Others

    Healthcare Cold Chain Logistics Market Mode of Delivery Outlook

    • Vaccines
    • Biopharmaceuticals
    • Clinical Trial Materials

    Healthcare Cold Chain Logistics Market Temperature Range Outlook

    • Ambient
    • Refrigerated
    • Frozen
    • Cryogenic

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2023 1.1(USD Billion)
    MARKET SIZE 2024 1.2(USD Billion)
    MARKET SIZE 2035 2.2(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 5.665% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Billion
    KEY COMPANIES PROFILED Panalpina, Kuehne + Nagel, AmerisourceBergen, Cardinal Health, Thermo Fisher Scientific, UPS, DHL, FedEx, XPO Logistics, C.H. Robinson, Royal Mail, Savi Technology, McKesson, Lineage Logistics, DB Schenker
    SEGMENTS COVERED Mode of Delivery, Product, Services, End User, Temperature Range
    KEY MARKET OPPORTUNITIES Temperature-sensitive drug demand growth, Biopharmaceutical industry expansion, Technological advancements in logistics, Regulatory compliance enhancements, Supply chain resilience improvements
    KEY MARKET DYNAMICS Regulatory compliance requirements, Increasing pharmaceutical demand, Technological advancements in logistics, Rising temperature-sensitive products, Focus on sustainability practices
    COUNTRIES COVERED US

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    What is the expected market size of the US Healthcare Cold Chain Logistics Market in 2024?

    The US Healthcare Cold Chain Logistics Market is expected to be valued at 1.2 billion USD in 2024.

    What will be the market value of the US Healthcare Cold Chain Logistics Market by 2035?

    By 2035, the market is projected to reach 2.2 billion USD.

    What is the expected CAGR for the US Healthcare Cold Chain Logistics Market from 2025 to 2035?

    The market is expected to grow at a CAGR of 5.665% between 2025 and 2035.

    Which mode of delivery is projected to dominate the US Healthcare Cold Chain Logistics Market?

    Both Last-Mile Delivery and Hubs-to-Distributor modes are projected to have equal market values at 0.6 billion USD in 2024.

    What will be the market value for Last-Mile Delivery in 2035?

    The market value for Last-Mile Delivery is anticipated to reach 1.1 billion USD by 2035.

    What will be the projected market size for Hubs-to-Distributor by 2035?

    The Hubs-to-Distributor mode is expected to achieve a market value of 1.1 billion USD by 2035.

    Who are the major players in the US Healthcare Cold Chain Logistics Market?

    Key players include Panalpina, Kuehne + Nagel, AmerisourceBergen, and Cardinal Health among others.

    What growth opportunities exist in the US Healthcare Cold Chain Logistics Market?

    Emerging trends and advancements in technology present significant growth opportunities in the market.

    How has the global scenario impacted the US Healthcare Cold Chain Logistics Market?

    Current global circumstances and logistical challenges continue to influence functions within the market.

    What is the market size for the US Healthcare Cold Chain Logistics Market in 2024 by specific modes of delivery?

    Both Last-Mile Delivery and Hubs-to-Distributor modes are valued at 0.6 billion USD in 2024.

    How much is the US Healthcare Cold Chain Logistics Market projected to grow by 2035?

    By 2035, the market is projected to grow to 2.85 billion USD.

    What is the expected compound annual growth rate (CAGR) for the US Healthcare Cold Chain Logistics Market from 2025 to 2035?

    The US Healthcare Cold Chain Logistics Market is expected to have a CAGR of 8.581 percent from 2025 to 2035.

    Which mode of delivery has a significant market value in the US Healthcare Cold Chain Logistics Market for 2024?

    Last-Mile Delivery is valued at 0.57 billion USD in 2024.

    What is the market size for the Hubs-to-Distributor segment in 2024?

    The Hubs-to-Distributor segment is valued at 0.58 billion USD in 2024.

    What will be the market size for Last-Mile Delivery by 2035?

    The market size for Last-Mile Delivery is projected to reach 1.39 billion USD by 2035.

    How much will the Hubs-to-Distributor segment be worth by 2035?

    By 2035, the Hubs-to-Distributor segment is expected to be valued at 1.46 billion USD.

    Can you name some key players in the US Healthcare Cold Chain Logistics Market?

    Key players include DHL Supply Chain, FedEx, UPS Healthcare, and Cardinal Health.

    What are some emerging trends in the US Healthcare Cold Chain Logistics Market?

    Emerging trends include increased demand for temperature-sensitive deliveries and advanced tracking technologies.

    What challenges does the US Healthcare Cold Chain Logistics Market face?

    Challenges include regulatory compliance and the rising cost of specialized logistics solutions.

    1. EXECUTIVE SUMMARY
    2. Market
    3. Overview
    4. Key Findings
    5. Market Segmentation
    6. Competitive Landscape
    7. Challenges
    8. and Opportunities
    9. Future Outlook
    10. MARKET INTRODUCTION
    11. Definition
    12. Scope of the study
    13. Research Objective
    14. Assumption
    15. Limitations
    16. RESEARCH
    17. METHODOLOGY
    18. Overview
    19. Data
    20. Mining
    21. Secondary Research
    22. Primary
    23. Research
    24. Primary Interviews and Information Gathering
    25. Process
    26. Breakdown of Primary Respondents
    27. Forecasting
    28. Model
    29. Market Size Estimation
    30. Bottom-Up
    31. Approach
    32. Top-Down Approach
    33. Data
    34. Triangulation
    35. Validation
    36. MARKET
    37. DYNAMICS
    38. Overview
    39. Drivers
    40. Restraints
    41. Opportunities
    42. MARKET FACTOR ANALYSIS
    43. Value chain Analysis
    44. Porter's
    45. Five Forces Analysis
    46. Bargaining Power of Suppliers
    47. Bargaining
    48. Power of Buyers
    49. Threat of New Entrants
    50. Threat
    51. of Substitutes
    52. Intensity of Rivalry
    53. COVID-19
    54. Impact Analysis
    55. Market Impact Analysis
    56. Regional
    57. Impact
    58. Opportunity and Threat Analysis
    59. U.S.
    60. Healthcare Cold Chain Logistics Market, BY Mode of Delivery (USD Billion)
    61. Last-Mile
    62. Delivery
    63. Hubs-to-Distributor
    64. U.S.
    65. Healthcare Cold Chain Logistics Market, BY Product (USD Billion)
    66. Vaccines
    67. Biopharmaceuticals
    68. Clinical
    69. Trial Materials
    70. U.S. Healthcare
    71. Cold Chain Logistics Market, BY Services (USD Billion)
    72. Transportation
    73. Storage
    74. Packaging
    75. Labeling
    76. Others
    77. U.S.
    78. Healthcare Cold Chain Logistics Market, BY End User (USD Billion)
    79. Hospitals
    80. Clinics
    81. Pharmaceutical
    82. Biopharmaceutical
    83. Biotechnology
    84. Companies
    85. Others
    86. U.S.
    87. Healthcare Cold Chain Logistics Market, BY Temperature Range (USD Billion)
    88. Ambient
    89. Refrigerated
    90. Frozen
    91. Cryogenic
    92. Competitive Landscape
    93. Overview
    94. Competitive
    95. Analysis
    96. Market share Analysis
    97. Major
    98. Growth Strategy in the Healthcare Cold Chain Logistics Market
    99. Competitive
    100. Benchmarking
    101. Leading Players in Terms of Number of Developments
    102. in the Healthcare Cold Chain Logistics Market
    103. Key developments
    104. and growth strategies
    105. New Product Launch/Service Deployment
    106. Merger
    107. Acquisitions
    108. Joint Ventures
    109. Major
    110. Players Financial Matrix
    111. Sales and Operating Income
    112. Major
    113. Players RD Expenditure. 2023
    114. Company
    115. Profiles
    116. Panalpina
    117. Financial
    118. Overview
    119. Products Offered
    120. Key
    121. Developments
    122. SWOT Analysis
    123. Key
    124. Strategies
    125. Kuehne + Nagel
    126. Financial
    127. Overview
    128. Products Offered
    129. Key
    130. Developments
    131. SWOT Analysis
    132. Key
    133. Strategies
    134. AmerisourceBergen
    135. Financial
    136. Overview
    137. Products Offered
    138. Key
    139. Developments
    140. SWOT Analysis
    141. Key
    142. Strategies
    143. Cardinal Health
    144. Financial
    145. Overview
    146. Products Offered
    147. Key
    148. Developments
    149. SWOT Analysis
    150. Key
    151. Strategies
    152. Thermo Fisher Scientific
    153. Financial
    154. Overview
    155. Products Offered
    156. Key
    157. Developments
    158. SWOT Analysis
    159. Key
    160. Strategies
    161. UPS
    162. Financial
    163. Overview
    164. Products Offered
    165. Key
    166. Developments
    167. SWOT Analysis
    168. Key
    169. Strategies
    170. DHL
    171. Financial
    172. Overview
    173. Products Offered
    174. Key
    175. Developments
    176. SWOT Analysis
    177. Key
    178. Strategies
    179. FedEx
    180. Financial
    181. Overview
    182. Products Offered
    183. Key
    184. Developments
    185. SWOT Analysis
    186. Key
    187. Strategies
    188. XPO Logistics
    189. Financial
    190. Overview
    191. Products Offered
    192. Key
    193. Developments
    194. SWOT Analysis
    195. Key
    196. Strategies
    197. C.H. Robinson
    198. Financial
    199. Overview
    200. Products Offered
    201. Key
    202. Developments
    203. SWOT Analysis
    204. Key
    205. Strategies
    206. Royal Mail
    207. Financial
    208. Overview
    209. Products Offered
    210. Key
    211. Developments
    212. SWOT Analysis
    213. Key
    214. Strategies
    215. Savi Technology
    216. Financial
    217. Overview
    218. Products Offered
    219. Key
    220. Developments
    221. SWOT Analysis
    222. Key
    223. Strategies
    224. McKesson
    225. Financial
    226. Overview
    227. Products Offered
    228. Key
    229. Developments
    230. SWOT Analysis
    231. Key
    232. Strategies
    233. Lineage Logistics
    234. Financial
    235. Overview
    236. Products Offered
    237. Key
    238. Developments
    239. SWOT Analysis
    240. Key
    241. Strategies
    242. DB Schenker
    243. Financial
    244. Overview
    245. Products Offered
    246. Key
    247. Developments
    248. SWOT Analysis
    249. Key
    250. Strategies
    251. References
    252. Related
    253. Reports
    254. LIST
    255. OF ASSUMPTIONS
    256. U.S. Healthcare Cold Chain Logistics Market
    257. SIZE ESTIMATES & FORECAST, BY MODE OF DELIVERY, 2019-2035 (USD Billions)
    258. U.S.
    259. Healthcare Cold Chain Logistics Market SIZE ESTIMATES & FORECAST, BY PRODUCT,
    260. 2035 (USD Billions)
    261. U.S. Healthcare Cold Chain Logistics
    262. Market SIZE ESTIMATES & FORECAST, BY SERVICES, 2019-2035 (USD Billions)
    263. U.S.
    264. Healthcare Cold Chain Logistics Market SIZE ESTIMATES & FORECAST, BY END USER,
    265. 2035 (USD Billions)
    266. U.S. Healthcare Cold Chain Logistics
    267. Market SIZE ESTIMATES & FORECAST, BY TEMPERATURE RANGE, 2019-2035 (USD Billions)
    268. PRODUCT
    269. LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    270. ACQUISITION/PARTNERSHIP
    271. LIST
    272. Of figures
    273. MARKET SYNOPSIS
    274. U.S.
    275. HEALTHCARE COLD CHAIN LOGISTICS MARKET ANALYSIS BY MODE OF DELIVERY
    276. U.S.
    277. HEALTHCARE COLD CHAIN LOGISTICS MARKET ANALYSIS BY PRODUCT
    278. U.S.
    279. HEALTHCARE COLD CHAIN LOGISTICS MARKET ANALYSIS BY SERVICES
    280. U.S.
    281. HEALTHCARE COLD CHAIN LOGISTICS MARKET ANALYSIS BY END USER
    282. U.S.
    283. HEALTHCARE COLD CHAIN LOGISTICS MARKET ANALYSIS BY TEMPERATURE RANGE
    284. KEY
    285. BUYING CRITERIA OF HEALTHCARE COLD CHAIN LOGISTICS MARKET
    286. RESEARCH
    287. PROCESS OF MRFR
    288. DRO ANALYSIS OF HEALTHCARE COLD CHAIN
    289. LOGISTICS MARKET
    290. DRIVERS IMPACT ANALYSIS: HEALTHCARE
    291. COLD CHAIN LOGISTICS MARKET
    292. RESTRAINTS IMPACT ANALYSIS:
    293. HEALTHCARE COLD CHAIN LOGISTICS MARKET
    294. SUPPLY / VALUE
    295. CHAIN: HEALTHCARE COLD CHAIN LOGISTICS MARKET
    296. HEALTHCARE
    297. COLD CHAIN LOGISTICS MARKET, BY MODE OF DELIVERY, 2024 (% SHARE)
    298. HEALTHCARE
    299. COLD CHAIN LOGISTICS MARKET, BY MODE OF DELIVERY, 2019 TO 2035 (USD Billions)
    300. HEALTHCARE
    301. COLD CHAIN LOGISTICS MARKET, BY PRODUCT, 2024 (% SHARE)
    302. HEALTHCARE
    303. COLD CHAIN LOGISTICS MARKET, BY PRODUCT, 2019 TO 2035 (USD Billions)
    304. HEALTHCARE
    305. COLD CHAIN LOGISTICS MARKET, BY SERVICES, 2024 (% SHARE)
    306. HEALTHCARE
    307. COLD CHAIN LOGISTICS MARKET, BY SERVICES, 2019 TO 2035 (USD Billions)
    308. HEALTHCARE
    309. COLD CHAIN LOGISTICS MARKET, BY END USER, 2024 (% SHARE)
    310. HEALTHCARE
    311. COLD CHAIN LOGISTICS MARKET, BY END USER, 2019 TO 2035 (USD Billions)
    312. HEALTHCARE
    313. COLD CHAIN LOGISTICS MARKET, BY TEMPERATURE RANGE, 2024 (% SHARE)
    314. HEALTHCARE
    315. COLD CHAIN LOGISTICS MARKET, BY TEMPERATURE RANGE, 2019 TO 2035 (USD Billions)
    316. BENCHMARKING
    317. OF MAJOR COMPETITORS

    U.S. Healthcare Cold Chain Logistics Market Segmentation

    • Healthcare Cold Chain Logistics Market By Mode of Delivery (USD Billion, 2019-2035)

      • Last-Mile Delivery
      • Hubs-to-Distributor
    • Healthcare Cold Chain Logistics Market By Product (USD Billion, 2019-2035)

      • Vaccines
      • Biopharmaceuticals
      • Clinical Trial Materials
    • Healthcare Cold Chain Logistics Market By Services (USD Billion, 2019-2035)

      • Transportation
      • Storage
      • Packaging
      • Labeling
      • Others
    • Healthcare Cold Chain Logistics Market By End User (USD Billion, 2019-2035)

      • Hospitals Clinics
      • Pharmaceutical
      • Biopharmaceutical
      • Biotechnology Companies
      • Others
    • Healthcare Cold Chain Logistics Market By Temperature Range (USD Billion, 2019-2035)

      • Ambient
      • Refrigerated
      • Frozen
      • Cryogenic

    No infographic available

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials